Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
FVE invests in life sciences, particularly targeting areas with significant unmet medical needs such as cancer, neurodegeneration, mental health, pain, chronic inflammation, and sleep disorders. They employ a venture engineering approach to systematically de-risk intellectual property and commercial opportunities, investing across stages from pre-seed to Series C.
FVE's notable portfolio includes companies like Vakston, which develops Fc-fusion-based vaccines; Akston Biosciences, focusing on protein therapeutics for companion animals; and Cell IDx, known for advanced tissue diagnostics tools acquired by Danaher in 2022. Other companies include NeuroDex, Twilight, and LeviSense.
Submit your pitch through their website's contact form.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.